TrialInvestigational new drugs2010

Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer.

Sung Yong Oh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.